PTH · Invesco

Invesco Dorsey Wright Healthcare Momentum ETF

See how 56 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 19 August 2026Price US$60.21 as of 2 October 2026Coverage limitations apply

Core valuation

Trailing P/E-40.63×100.00% coverage

Latest-quarter run-rate P/E-67.10×100.00% coverage

Trailing P/S1.75×80.03% coverage

Latest-quarter run-rate P/S1.60×78.22% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
Holding	Weight	Trailing P/E	Trailing P/S
MRNAModerna Inc	5.46%	-23.94×	33.86×
RVMDRevolution Medicines Inc	5.12%	-24.96×	Unavailable
ROIVRoivant Sciences Ltd	4.94%	-96.31×	3404.47×
GHGuardant Health Inc	4.54%	-51.72×	19.82×
AXSMAxsome Therapeutics Inc	3.74%	-49.76×	12.28×
BTSGBrightSpring Health Services Inc	3.63%	30.96×	0.79×
ORKAOruka Therapeutics Inc	2.82%	-41.56×	Unavailable
TXG10X Genomics Inc	2.71%	-153.58×	18.70×
ERASErasca Inc	2.65%	-17.75×	Unavailable
LQDALiquidia Corp	2.44%	18.08×	5.56×

Top 10 of 56 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

XBI · State Street SPDR S&P Biotech ETF24.84% holdings overlap · NYSE Arca
IBB · iShares Biotechnology ETF19.62% holdings overlap · US market
GNOM · Global X Genomics & Biotechnology ETF18.90% holdings overlap · Nasdaq
FMED · Fidelity Disruptive Medicine ETF17.21% holdings overlap · Nasdaq
FTXH · First Trust Nasdaq Pharmaceuticals ETF17.03% holdings overlap · Nasdaq

Sources and limitations

Holdings are sourced from Invesco and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 19 August 2026. Informational research, not investment advice.